Skip to main content

Supplement guide

Saccharomyces boulardii: Yeast Probiotic Evidence and Safety

Saccharomyces boulardii is a live yeast probiotic. Results differ across studies of diarrhea during antibiotic use. Serious bloodstream infection is a documented concern in some vulnerable patients.

Published by LongevityMate Editorial · Updated 2026-11-08 · 4 minute read

The short answer

What is Saccharomyces boulardii?

Saccharomyces boulardii is a live yeast used in some probiotics. It has been studied for diarrhea associated with antibiotics, with mixed results. The preparation, the people studied and the way diarrhea was defined all affect how much a study can tell you. In vulnerable patients, the yeast has been associated with serious bloodstream infections.See reference 1,See reference 2,See reference 3,See reference 4

Conceptual illustration of oval yeast cells with smaller buds attached, representing Saccharomyces boulardii.
On this page

What different studies actually measured

Research question
Diarrhea during antibiotic use across trials
What researchers found
A 2015 meta-analysis found fewer episodes across pooled child and adult trials.
What limits the finding
The trials used their own diarrhea definitions. The average does not establish a predictable benefit for every product or person.See reference 2
Research question
Adults taking antibiotics in hospital
What researchers found
A 477-person randomized trial found no clear benefit. A 2026 trial of 100 adults at one hospital reported fewer episodes with the freeze-dried preparation it tested.
What limits the finding
The newer trial followed people for 28 days and counted at least two loose stools in 24 hours. The unusually high placebo event rate and different definitions limit comparisons.See reference 3,See reference 4
Research question
Prevention of C. difficile infection
What researchers found
Professional guidance differs. AGA made a conditional suggestion for selected formulations, including this yeast. ACG recommended against routine probiotic use for primary prevention in people taking antibiotics.
What limits the finding
Diarrhea and laboratory-confirmed infection are different outcomes. No C. difficile infection events occurred in either arm of the newer trial.See reference 4,See reference 5,See reference 6

Read the yeast and strain information

Start with the full organism name, then look for a strain code, a stated live count and any storage instructions. Colony-forming units (CFU) describe the number of viable microorganisms measured under defined conditions. A brand or a larger combined CFU count for a blend does not establish that it matches a studied preparation.See reference 2,See reference 7

Study formulations can differ. The 2026 trial used a specified freeze-dried preparation. The studied preparation and follow-up explain the result, while a health professional can assess whether any supplement is suitable for an individual.See reference 4,See reference 7

Who needs particular caution

Hospital reports link this yeast probiotic to fungemia, meaning yeast in the bloodstream. In a five-hospital Finnish study, at least 20 of 46 patients with Saccharomyces fungemia had been using the probiotic. This selected group cannot tell us the chance of infection for an average user.See reference 1

The study authors cautioned against use in patients who were critically ill, had a weakened immune system or had an indwelling catheter. These patients and anyone with complex medical care need advice from their treating team before considering a live yeast supplement.See reference 1

Common questions

Does it work like a bacterial probiotic?

It contains a yeast. Research on one organism or formulation does not automatically apply to another probiotic.See reference 2,See reference 7

Does evidence for fewer loose stools prove prevention of C. difficile infection?

These are different outcomes. Studies need confirmed infection events to answer the second question, and professional recommendations differ.See reference 4,See reference 5,See reference 6

Does a trial settle how much I should take?

A study can describe what a specific group received. A personal decision depends on the product, the reason for use and the person’s medical circumstances.See reference 1,See reference 3,See reference 4

Get the weekly longevity brief

The week's best longevity research in plain English. Free, every Tuesday.

References

  1. 1. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements

    Emerging Infectious DiseasesObservational study

  2. 2. Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea: systematic review and meta-analysis

    Alimentary Pharmacology & TherapeuticsMeta-analysis

  3. 3. Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: a randomized trial

    Open Forum Infectious DiseasesRandomized trial

  4. 4. Saccharomyces boulardii for Prevention of Antibiotic-Associated Diarrhea in Hospitalized Patients

    AntibioticsRandomized trial

  5. 5. Role of probiotics in the management of gastrointestinal disorders

    American Gastroenterological AssociationGuideline

  6. 6. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections

    American Journal of GastroenterologyGuideline

  7. 7. Probiotics and Prebiotics

    World Gastroenterology OrganisationGuideline

Editorial transparency

Published by
LongevityMate Editorial
Reviewed by
Editorial evidence review (AI-assisted)
Published
Updated

Medical disclaimer

General education. Personal results, diagnoses, treatment and supplement decisions require a qualified health professional.